Protalix BioTherapeutics Statistics

Total Valuation

PLX has a market cap or net worth of $75.01 million. The enterprise value is $56.14 million.

Market Cap	75.01M
Enterprise Value	56.14M

Important Dates

The next estimated earnings date is Monday, November 4, 2024, before market open.

Earnings Date	Nov 4, 2024
Ex-Dividend Date	n/a

Share Statistics

PLX has 73.54 million shares outstanding. The number of shares has increased by 12.82% in one year.

Shares Outstanding	73.54M
Shares Change (YoY)	+12.82%
Shares Change (QoQ)	+0.37%
Owned by Insiders (%)	11.38%
Owned by Institutions (%)	9.36%
Float	54.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	3.00
PS Ratio	1.95
Forward PS	1.96
PB Ratio	2.62
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.48
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.33, with a Debt / Equity ratio of 0.92.

Current Ratio	1.33
Quick Ratio	0.95
Debt / Equity	0.92
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-8.36

Financial Efficiency

Return on equity (ROE) is -43.48% and return on invested capital (ROIC) is -15.44%.

Return on Equity (ROE)	-43.48%
Return on Assets (ROA)	-10.27%
Return on Capital (ROIC)	-15.44%
Revenue Per Employee	$182,947
Profits Per Employee	-$70,644
Employee Count	208
Asset Turnover	0.42
Inventory Turnover	1.28

Taxes

Income Tax	-456,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -38.41% in the last 52 weeks. The beta is 0.70, so PLX's price volatility has been lower than the market average.

Beta (5Y)	0.70
52-Week Price Change	-38.41%
50-Day Moving Average	1.02
200-Day Moving Average	1.25
Relative Strength Index (RSI)	45.64
Average Volume (20 Days)	121,232

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PLX had revenue of $38.05 million and -$14.69 million in losses. Loss per share was -$0.20.

Revenue	38.05M
Gross Profit	12.25M
Operating Income	-14.79M
Pretax Income	6.77M
Net Income	-14.69M
EBITDA	-13.53M
EBIT	-14.79M
Loss Per Share	-$0.20

Full Income Statement

Balance Sheet

The company has $45.03 million in cash and $26.15 million in debt, giving a net cash position of $18.88 million or $0.26 per share.

Cash & Cash Equivalents	45.03M
Total Debt	26.15M
Net Cash	18.88M
Net Cash Per Share	$0.26
Equity (Book Value)	28.58M
Book Value Per Share	0.39
Working Capital	19.40M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$2.72 million and capital expenditures -$1.47 million, giving a free cash flow of -$4.18 million.

Operating Cash Flow	-2.72M
Capital Expenditures	-1.47M
Free Cash Flow	-4.18M
FCF Per Share	-$0.06

Full Cash Flow Statement

Margins

Gross margin is 32.18%, with operating and profit margins of -38.85% and -38.61%.

Gross Margin	32.18%
Operating Margin	-38.85%
Pretax Margin	-39.81%
Profit Margin	-38.61%
EBITDA Margin	-35.55%
EBIT Margin	-38.85%
FCF Margin	7.32%

Dividends & Yields

PLX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.82%
Shareholder Yield	-12.82%
Earnings Yield	-19.59%
FCF Yield	-5.57%

Analyst Forecast

The average price target for PLX is $10.00, which is 880.39% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.00
Price Target Difference	880.39%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on December 20, 2019. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Dec 20, 2019
Split Type	Reverse
Split Ratio	0.1:1

Scores

PLX has an Altman Z-Score of -4.77 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.77
Piotroski F-Score	1